| Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete) |
|||
|
OVERVIEW |
|||
| SERIAL NUMBER | 88584518 | FILING DATE | 08/19/2019 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | GULIANO, ROBERT N | L.O. ASSIGNED | 105 |
|
PUB INFORMATION |
|||
| RUN DATE | 08/18/2020 | ||
| PUB DATE | N/A | ||
| STATUS | 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED | ||
| STATUS DATE | 08/17/2020 | ||
| LITERAL MARK ELEMENT | EVEREST | ||
|
|
|||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A |
|
|
|
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | YES | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | NO | 1 (b) | YES | 1 (b) | YES |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO |
|
|
| NO BASIS | NO | NO BASIS | NO |
|
|
|
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | EVEREST |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
|
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | EverNov Medicines Limited |
| ADDRESS | 66th Floor, Tower 1, Plaza 66 West Nanjing 1266 Shanghai, 200040 |
| ENTITY | 16-LTD LIAB CO |
| CITIZENSHIP | China |
|
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 001 |
| DESCRIPTION TEXT | Active chemical ingredients for use in the manufacture of anti-cancer drugs; chemical additives for use in the manufacture of medicines; chemical substances for use in the production of drugs |
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceuticals, namely, pharmaceutical preparations for treating diseases and conditions in the field of oncology/hematology, immunology, cardiology, renal diseases, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory diseases, metabolic diseases, dermatology, and gastrointestinal or women's health; pharmaceutical drugs, namely, pharmaceutical preparations for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, and gastrointestinal or women's health; pharmaceutical preparations for health care, namely, for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, and gastrointestinal or women's health; pharmaceutical preparations for oral, intravenous, topical, parenteral, rectal or sublingual use in connection with humans for oncology/hematology, immunology, cardiology, renal diseases, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory diseases, metabolic diseases, dermatology, and gastrointestinal or women's health |
|
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 001 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
|
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
|
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 08/17/2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 024 |
| 08/17/2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 023 |
| 08/17/2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 022 |
| 08/03/2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 021 |
| 08/03/2020 | GNRT | O | NON-FINAL ACTION E-MAILED | 020 |
| 08/03/2020 | CNRT | R | NON-FINAL ACTION WRITTEN | 019 |
| 07/13/2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 018 |
| 07/13/2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 017 |
| 07/06/2020 | ALIE | A | ASSIGNED TO LIE | 016 |
| 06/24/2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 015 |
| 06/04/2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 014 |
| 06/04/2020 | GNRT | O | NON-FINAL ACTION E-MAILED | 013 |
| 06/04/2020 | CNRT | R | NON-FINAL ACTION WRITTEN | 012 |
| 05/20/2020 | DOCK | D | ASSIGNED TO EXAMINER | 011 |
| 04/16/2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 010 |
| 04/15/2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 009 |
| 04/15/2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 008 |
| 11/20/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 007 |
| 11/20/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 006 |
| 11/20/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 005 |
| 11/18/2019 | DOCK | D | ASSIGNED TO EXAMINER | 004 |
| 10/16/2019 | LOPT | I | LETTER OF PROTEST ACCEPTED | 003 |
| 09/04/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 08/22/2019 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
|
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | David Devernoe |
| CORRESPONDENCE ADDRESS | David Devernoe RIMON, P.C. 440 STEVENS AVE., SUITE 200 SOLANA BEACH CA 92075 |
| DOMESTIC REPRESENTATIVE | NONE |